Follow
Alan J Thompson
Alan J Thompson
Professor of Clinical Neurology and Neurorehabilitation, University College London
Verified email at ucl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ...
Annals of neurology 69 (2), 292-302, 2011
98902011
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis
WI McDonald, A Compston, G Edan, D Goodkin, HP Hartung, FD Lublin, ...
Annals of Neurology: Official Journal of the American Neurological …, 2001
87542001
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
CH Polman, SC Reingold, G Edan, M Filippi, HP Hartung, L Kappos, ...
Annals of Neurology: Official Journal of the American Neurological …, 2005
62532005
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
41502018
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
38372021
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ...
The lancet 390 (10100), 1151-1210, 2017
38002017
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
27942014
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging
TEJ Behrens, H Johansen-Berg, MW Woolrich, SM Smith, ...
Nature neuroscience 6 (7), 750-757, 2003
24592003
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
21642020
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
GR Cutter, ML Baier, RA Rudick, DL Cookfair, JS Fischer, J Petkau, ...
Brain 122 (5), 871-882, 1999
13311999
Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity
P Browne, D Chandraratna, C Angood, H Tremlett, C Baker, BV Taylor, ...
Neurology 83 (11), 1022-1024, 2014
12022014
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
11912020
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
PA Brex, O Ciccarelli, JI O'Riordan, M Sailer, AJ Thompson, DH Miller
New England Journal of Medicine 346 (3), 158-164, 2002
11452002
Neural correlates of motor recovery after stroke: a longitudinal fMRI study
NS Ward, MM Brown, AJ Thompson, RSJ Frackowiak
Brain 126 (11), 2476-2496, 2003
10932003
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
LK Fisniku, PA Brex, DR Altmann, KA Miszkiel, CE Benton, R Lanyon, ...
Brain 131 (3), 808-817, 2008
10742008
The multiple sclerosis impact scale (MSIS-29) a new patient-based outcome measure
J Hobart, D Lamping, R Fitzpatrick, A Riazi, A Thompson
Brain 124 (5), 962-973, 2001
10462001
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek, P Fox, H Sanders, D Wright, J Vickery, A Nunn, A Thompson, ...
The lancet 362 (9395), 1517-1526, 2003
9562003
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
9442021
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
D Miller, F Barkhof, X Montalban, A Thompson, M Filippi
The Lancet Neurology 4 (5), 281-288, 2005
8462005
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability
JHTM Van Waesberghe, W Kamphorst, CJA De Groot, ...
Annals of Neurology: Official Journal of the American Neurological …, 1999
8421999
The system can't perform the operation now. Try again later.
Articles 1–20